Advertisement
Among patients participating in a chemotherapy drug trial

Cancer Patients Vary in Survival Benefit Needed to Justify Chemo

0
And, generally, physicians are less likely to accept chemotherapy for modest survival benefit
Magnetic resonance imaging-targeted biopsy could reduce the need for biopsies and overdiagnosis with low-grade prostate cancer

MRI-Based Strategy Reduces Biopsies in Prostate CA Screening

0
MRI-based screening could reduce unnecessary biopsies, overdiagnosis of low-grade cancer
From 1992 to 2014 there was a decrease in the rate of malpractice claims paid on behalf of physicians in the United States

Paid Malpractice Claims Cut in Half From 1992 to 2014 in U.S.

0
But, increase in mean compensation amounts and percentage of paid claims exceeding $1 million
For patients on dialysis

Mortality Risk Impacts Colon CA Screening in Dialysis Patients

0
Higher rate of screening among patients most likely to receive a transplant
The risk of preterm birth and low birth weight is increased for live births for adolescent and young adult cancer survivors (diagnosed at ages 15 to 39)

Higher Risk of Adverse Outcomes for Births to Young CA Survivors

0
Increased risks among live births for adolescent and young adult cancer survivors
After 180 countries agreed to a global tobacco control treaty in 2005

Global Tobacco Control Treaty Has Reduced Smoking Rates

0
Countries agreed to implement measures such as tobacco taxes and smoke-free public areas
Patients admitted to the hospital during The Joint Commission on-site inspections (surveys) have reduced mortality compared to that seen during non-survey weeks

30-Day Mortality Down During Joint Commission Survey Weeks

0
Patients admitted during survey weeks (versus non-survey weeks) have significantly lower mortality
Follow-up care delivered via a mobile app can reduce in-person visits for ambulatory patients undergoing breast reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

0
Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon
Bavencio (avelumab) has been approved by the U.S. Food and Drug Administration to treat Merkel cell carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

0
Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States
Acetylsalicylic acid hyporesponsiveness after coronary artery bypass graft surgery can be overcome by multiple dosing

Multiple Dosing Mitigates ASA Hyporesponsiveness After CABG

0
Multiple dosing more effective than ASA 81 or 325 mg once-daily for suppressing serum TXB2 formation